RU2319501C2 - Способ лечения болезни альцгеймера - Google Patents

Способ лечения болезни альцгеймера Download PDF

Info

Publication number
RU2319501C2
RU2319501C2 RU2003134949/14A RU2003134949A RU2319501C2 RU 2319501 C2 RU2319501 C2 RU 2319501C2 RU 2003134949/14 A RU2003134949/14 A RU 2003134949/14A RU 2003134949 A RU2003134949 A RU 2003134949A RU 2319501 C2 RU2319501 C2 RU 2319501C2
Authority
RU
Russia
Prior art keywords
lhrh antagonist
lhrh
antagonist
methyl
per month
Prior art date
Application number
RU2003134949/14A
Other languages
English (en)
Russian (ru)
Other versions
RU2003134949A (ru
Inventor
Райнер ФЁГЕЛИ (DE)
Райнер ФЁГЕЛИ
Юрген ЭНГЕЛЬ (DE)
Юрген Энгель
Original Assignee
Центарис Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Центарис Гмбх filed Critical Центарис Гмбх
Publication of RU2003134949A publication Critical patent/RU2003134949A/ru
Application granted granted Critical
Publication of RU2319501C2 publication Critical patent/RU2319501C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
RU2003134949/14A 2001-04-30 2002-04-27 Способ лечения болезни альцгеймера RU2319501C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28743401P 2001-04-30 2001-04-30
US60/287,434 2001-04-30

Publications (2)

Publication Number Publication Date
RU2003134949A RU2003134949A (ru) 2005-02-10
RU2319501C2 true RU2319501C2 (ru) 2008-03-20

Family

ID=23102886

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2003134949/14A RU2319501C2 (ru) 2001-04-30 2002-04-27 Способ лечения болезни альцгеймера

Country Status (27)

Country Link
US (1) US7288517B2 (enExample)
EP (1) EP1392348B1 (enExample)
JP (1) JP2004529207A (enExample)
KR (1) KR20040000446A (enExample)
CN (1) CN1317030C (enExample)
AT (1) ATE400287T1 (enExample)
AU (1) AU2002310788B2 (enExample)
BG (1) BG108339A (enExample)
BR (1) BR0209290A (enExample)
CA (1) CA2444876A1 (enExample)
CZ (1) CZ20033167A3 (enExample)
DE (1) DE60227507D1 (enExample)
DK (1) DK1392348T3 (enExample)
ES (1) ES2307760T3 (enExample)
HU (1) HUP0400067A2 (enExample)
IL (1) IL156777A0 (enExample)
MX (1) MXPA03008666A (enExample)
NO (1) NO20034322L (enExample)
NZ (1) NZ544417A (enExample)
PL (1) PL362319A1 (enExample)
PT (1) PT1392348E (enExample)
RU (1) RU2319501C2 (enExample)
SI (1) SI1392348T1 (enExample)
SK (1) SK14512003A3 (enExample)
UA (1) UA80679C2 (enExample)
WO (1) WO2002102401A1 (enExample)
ZA (1) ZA200305326B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) * 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
US20020077327A1 (en) * 1999-09-23 2002-06-20 Neurocrine Biosciences, Inc. Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
PT1300398E (pt) 2000-07-05 2006-07-31 Astellas Pharma Inc Processos e composicoes para terapias do cancro, utilizando genes que codificam o interferao-beta
DE10137174A1 (de) * 2001-07-31 2003-02-13 Zentaris Ag Verwendung von LHRH-Antagonisten in nichtkastrierenden Dosen zur Verbesserung der T-Zellen-vermittelten Immunität
MXPA06014131A (es) * 2004-06-04 2007-03-07 Astellas Pharma Inc Derivado de propano-1,3-diona o su sal.
US20080171736A1 (en) * 2004-12-23 2008-07-17 Gregory Christopher W Treatment of Alzheimer's Disease and Mild Cognitive impairment using GnRH-I analogs and one or more of acetylcholinesterase inhibitors and NMDA receptor antagonists
EP2425846A1 (en) * 2004-12-23 2012-03-07 Voyager Pharmaceutical Corporation Acetylcholinesterase Inhibitors and leuprolide acetate for the treatment of Alzheimer's disease
SI1864976T1 (sl) * 2005-03-31 2012-12-31 Astellas Pharma Inc. Propan-1,3-dionski derivat ali njegova sol
WO2008046919A2 (en) * 2006-10-21 2008-04-24 Abbott Gmbh & Co. Kg Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors
AU2008303928A1 (en) * 2007-09-11 2009-04-02 Mondobiotech Laboratories Ag Use of NF-KAPPAB inhibitor SN50 and optionally angiotensin III as therapeutic agents in the treatment of EG HBV infection
AU2008306264A1 (en) * 2007-09-11 2009-04-09 Mondobiotech Laboratories Ag Use of a platelet fibrinogen receptor hexapeptide antagonist and alpha-endorphin as therapeutic agents
EP2095818A1 (en) 2008-02-29 2009-09-02 AEterna Zentaris GmbH Use of LHRH antagonists at non-castrating doses
EP2307040B1 (en) * 2008-05-29 2015-09-09 Isr Immune System Regulation Ab Use of gnrh and sex hormones for treating viral disease, in particular hiv/aids
US9266855B2 (en) 2010-09-27 2016-02-23 AbbVie Deutschland GmbH & Co. KG Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
US9090592B2 (en) 2010-12-30 2015-07-28 AbbVie Deutschland GmbH & Co. KG Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
EP3560555A1 (en) 2018-04-26 2019-10-30 LifeArc A composition for treating one or more estrogen related diseases
WO2025155903A1 (en) * 2024-01-19 2025-07-24 Temple University-Of The Commonwealth System Of Higher Education Compositions of antioxidant translation modulators for treating neurodegenerative disorders

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2309395A1 (en) * 1999-06-04 2000-12-04 Richard Lloyd Bowen Methods for preventing and treating alzheimer's disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3135743A (en) 1960-06-29 1964-06-02 Sterling Drug Inc Steroido[2. 3-d]isoxazoles and preparation thereof
CA2254769A1 (en) 1996-05-20 1997-11-27 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
DE19911771B4 (de) * 1999-03-17 2006-03-30 Zentaris Gmbh LHRH-Antagonist, Verfahren zu seiner Herstellung und seiner Verwendung
EP1185530A1 (en) 1999-05-14 2002-03-13 Neurocrine Biosciences, Inc. Imidazo- and pyrrolo[1,2-a]pyrimid-4-ones as gonadotropin-releasing hormone receptor antagonists
MXPA02003614A (es) 1999-10-15 2002-10-23 Neurocrine Biosciences Inc Antagonistas del receptor de la hormona liberadora de ganadotropina y metodos relacionados con los mismos..
US20030134863A1 (en) 2000-04-13 2003-07-17 Shuichi Furuya Preventives/remedies for alzheimer's disease
PT1300398E (pt) * 2000-07-05 2006-07-31 Astellas Pharma Inc Processos e composicoes para terapias do cancro, utilizando genes que codificam o interferao-beta

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2309395A1 (en) * 1999-06-04 2000-12-04 Richard Lloyd Bowen Methods for preventing and treating alzheimer's disease

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
весь документ. *
п.30 формулы. Болезни нервной системы. Руководство под ред. Н.Н.Яхно и др. - М.: Медицина, 1995, с.144-159, 195-199, 205-217, 228-231. *
пример 1. *
с.10-12. *

Also Published As

Publication number Publication date
NO20034322D0 (no) 2003-09-26
EP1392348B1 (en) 2008-07-09
ZA200305326B (en) 2003-07-30
JP2004529207A (ja) 2004-09-24
SI1392348T1 (sl) 2008-12-31
RU2003134949A (ru) 2005-02-10
BR0209290A (pt) 2004-07-13
IL156777A0 (en) 2004-02-08
US7288517B2 (en) 2007-10-30
NZ544417A (en) 2008-03-28
CN1575185A (zh) 2005-02-02
SK14512003A3 (sk) 2004-08-03
DE60227507D1 (de) 2008-08-21
HK1072000A1 (en) 2005-08-12
PL362319A1 (en) 2004-10-18
CZ20033167A3 (cs) 2004-08-18
US20020177556A1 (en) 2002-11-28
DK1392348T3 (da) 2008-09-29
BG108339A (bg) 2004-11-30
PT1392348E (pt) 2008-09-09
HUP0400067A2 (hu) 2004-04-28
NO20034322L (no) 2003-09-26
MXPA03008666A (es) 2004-10-15
AU2002310788B2 (en) 2007-04-05
KR20040000446A (ko) 2004-01-03
CN1317030C (zh) 2007-05-23
WO2002102401A1 (en) 2002-12-27
ATE400287T1 (de) 2008-07-15
CA2444876A1 (en) 2002-12-27
EP1392348A1 (en) 2004-03-03
ES2307760T3 (es) 2008-12-01
UA80679C2 (en) 2007-10-25

Similar Documents

Publication Publication Date Title
ES2307760T3 (es) Tratamiento de la demencia y enfermedades neurodegenerativas con dosis intermedias de antagonistas de lhrh.
JP2006502969A (ja) 内因性性腺刺激ホルモン産生の増強
AU2002310788A1 (en) Treatment of dementia and neurodegenerative diseases with intermediate doses of LHRH antagonists
US20150080305A1 (en) Application of initial doses of lhrh analogues and maintenance doses of lhrh antagonists for the treatment of hormone-dependent cancers and corresponding pharmaceutical kits
DE69927705T2 (de) Verwendung von acetylcholinesterase inhibitoren zur modulierung der hypothalamus-hypophysen-gonadenachse
ES2247710T3 (es) Antagonista de gonadotropina.
RU2152222C1 (ru) Слаборастворимая соль аналога рг-лг, слаборастворимая соль аналога бомбезина, фармацевтическая композиция, медицинский препарат
RU2005113163A (ru) Фармацевтический гелевый препарат, способ его получения и соответствующий набор, способ лечения заболеваний с его использованием
RU2002111000A (ru) Способ терапевтического лечения внематочной пролиферации эндометриальной ткани, хронической боли в области таза и непроходимости фаллопиевых труб, фармацевтическая композиция и анатагонист LHRH-лекарственное средство для указанного лечения (варианты)
EP1297850B1 (en) Medicinal preparations for treating sex hormone-dependent diseases
EP3573663B1 (en) A composition comprising at least one gnrh antagonist
EP3560555A1 (en) A composition for treating one or more estrogen related diseases
US20030092628A1 (en) Gonadotropin releasing hormone antagonist
CN122028929A (zh) 用于治疗前列腺癌的替维瑞克-tfa的给药方案
JPH04506969A (ja) 成人男性における不妊症又は生殖能力低下の治療方法および該方法のための製剤の使用
AU6263800A (en) Gonadotropin releasing hormone antagonist
CN1199642A (zh) 治疗不育症的lhrh－拮抗剂
HK1072000B (en) Treatment of alzheimer's diseases with intemediate doses of lhrh antagonists
BE737895A (enExample)

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20080428